Jennifer Giltnane Selected Research

Jennifer Giltnane Research Topics

14	Neoplasms (Cancer) 01/2023 - 05/2006
7	Breast Neoplasms (Breast Cancer) 01/2023 - 05/2006
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 09/2014 - 01/2012
1	Hypersensitivity (Allergy) 09/2022
1	Melanoma (Melanoma, Malignant) 11/2017
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 11/2017
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2017
1	Carcinoma (Carcinomatosis) 11/2017
1	Brain Neoplasms (Brain Tumor) 11/2017
1	Mesothelioma 11/2017
1	Extranodal Extension 09/2017
1	Noninfiltrating Intraductal Carcinoma (DCIS) 09/2017
1	Lymphoma (Lymphomas) 09/2014
1	Eosinophilia 01/2012
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2012

4	Estrogen ReceptorsIBA 01/2023 - 04/2014
3	Proteins (Proteins, Gene)FDA Link 10/2017 - 05/2006
2	Hormones (Hormone)IBA 01/2023 - 04/2014
2	Hematoxylin (Haematoxylon)IBA 01/2021 - 09/2017
2	Eosine Yellowish-(YS) (Eosin)IBA 01/2021 - 09/2017
2	Biomarkers (Surrogate Marker)IBA 11/2017 - 09/2017
1	3- (4- (2- (2- chloro- 4- fluorophenyl)- 1- (1H- indazol- 5- yl)but- 1- en- 1- yl)phenyl)acrylic acidIBA 01/2023
1	palbociclibIBA 01/2023
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 01/2023
1	Progesterone FDA LinkGeneric 09/2022
1	Estrogen Receptor alphaIBA 09/2022
1	giredestrantIBA 09/2022
1	atezolizumabIBA 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	RNA (Ribonucleic Acid)IBA 12/2021
1	LigandsIBA 12/2021
1	Chemokine ReceptorsIBA 12/2021
1	Formaldehyde (Formol)FDA Link 01/2021
1	Nucleic AcidsIBA 01/2021
1	ParaffinIBA 01/2021
1	Trastuzumab (Herceptin)FDA Link 01/2017
1	Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA 09/2014
1	Imatinib Mesylate (Gleevec)FDA Link 01/2012
1	Tyrosine (L-Tyrosine)FDA Link 01/2012
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2012
1	Phosphotransferases (Kinase)IBA 01/2012
1	beta CateninIBA 05/2006